Targeting GLP-1 receptor trafficking to improve agonist efficacy (2018)
Attributed to:
Targeting etiologic molecular mechanisms to treat human diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.60692/c17nj-ce168
Publication URI: https://gresis.osc.int//doi/10.60692/c17nj-ce168
Type: Other